"Multi-stakeholder approach" key to sustainable biosimilars market, says EGA
This article was originally published in Scrip
Executive Summary
Among the numerous challenges facing the biosimilars market are winning the trust of all stakeholders in the biosimilars concept, tackling misinformation, and encouraging the implementation of policies that can ensure the sustainability of the market in the long run.